Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Projected to Expand at 8.5% CAGR by 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Likely To Evolve From 2025 Through 2034?
The veterinary active pharmaceutical ingredients manufacturing market has demonstrated strong growth in recent years. Its market size is anticipated to expand from $7.46 billion in 2024 to $8.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.7%. The historical expansion can be ascribed to factors including increasing pet ownership, rigorous regulatory standards, a greater emphasis on animal nutrition, investments in research and development, and overall global economic growth.
The veterinary active pharmaceutical ingredients manufacturing market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $11.12 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. This expansion over the forecast period is primarily driven by factors such as progress in personalized veterinary medicine, increasing globalization and market reach, a strong emphasis on regulatory adherence, the rising significance of animal welfare, innovations in drug delivery mechanisms, and an escalating demand for nutraceutical products. Key developments expected during this timeframe encompass technological improvements in production methods, a rise in the outsourcing of API manufacturing, a transition towards biotechnology-derived APIs, greater digitalization and automation in production, and the worldwide integration of the veterinary API market.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
What Are The Main Drivers Boosting The Veterinary Active Pharmaceutical Ingredients Manufacturing Industry’s Expansion?
A rise in the population of pet owners is anticipated to fuel expansion within the veterinary active pharmaceutical ingredients manufacturing market in the future. These pet owners are individuals who either possess or adopt a companion animal. Their provision of essential healthcare facilities for these pets consequently boosts the demand for veterinary drugs. For example, in 2022, according to Animal Medicines Australia, an Australia-based non-governmental organization, pet ownership in Australia saw significant growth, with the number of pet owners reaching 28,730.8 in 2022, an increase from 39% in 2021. This figure represents a 24% rise, underscoring a strong upward trend in both pet adoption and investment in their care. The substantial increase in pet ownership further highlights the growing popularity of pets in Australian households. Consequently, the expanding number of pet owners is a primary driver for the veterinary active pharmaceutical ingredients manufacturing market.
What Are The Leading Segments Analyzed In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
Which Market Trends Are Creating New Opportunities In The Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
A significant trend emerging in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. Leading companies within the sector are concentrating on developing novel products to maintain their standing. For example, in January 2022, Zoetis Inc., a US-based pets and livestock drug company, revealed that its Solensia (frunevetmab injection) received US FDA approval for managing osteoarthritis (OA) pain in felines. In the United States, Solensia stands as the sole approved injectable monoclonal antibody treatment specifically for feline OA pain. Its mechanism involves targeting and neutralizing nerve growth factor (NGF), which is a primary contributor to osteoarthritis pain.
Which Key Market Players Are Investing In Expansion And Innovation Of Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.
Download The Full Report For Exclusive Market Findings:
How Is Veterinary Active Pharmaceutical Ingredients Manufacturing Market Demand Varying Across Different Regions?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp
Browse Through More Reports Similar to the Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market 2025, By The Business Research Company
Veterinary Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2025
Veterinary Patient Monitoring Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model